Recurrent carcinoma in situ of a neovagina.
BACKGROUND
Development of carcinoma in situ in a neovagina is rare.


METHODS
A case of carcinoma in situ of a neovagina complicated by recurrence after ablative therapy is discussed. Recurrence occurred within 4 months of initial therapy, and a total vaginectomy was performed after the patient declined other therapeutic options.


CONCLUSIONS
Recurrent carcinoma in situ of a neovagina can be successfully treated by surgical excision.
Lowe
M P
MP
Division of Gynecology Oncology, University of Iowa Hospitals and Clinics, Iowa City, Iowa 52242, USA.
Ault
K A
KA
Sood
A K
AK
D002278:Carcinoma in Situ / Q000209:etiology / Q000473:pathology / Q000601:surgery*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000209:etiology / Q000473:pathology / Q000601:surgery*; D016038:Skin Transplantation; D014621:Vagina / Q000002:abnormalities / Q000601:surgery*; D014625:Vaginal Neoplasms / Q000209:etiology / Q000473:pathology / Q000601:surgery*